CalciMedica Inc. (CALC)

NASDAQ: CALC · Real-Time Price · USD

1.52

0.01 (0.66%)

At close: Apr 29, 2025, 3:54 PM

CalciMedica Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	7.93M	9.15M	5.06M	6.75M	5.53M	11.64M	19.08M	24.39M	17.3M	10.17M	13.87M	8.36M	13.36M	11.45M	7.86M	10.59M	33.42M	94.97M	17.54M	15.87M
Short-Term Investments	10.73M	5.45M	14.08M	18.95M	5.71M	2.95M	n/a	9.78M	21.82M	33.46M	36.82M	46.92M	50.31M	61.1M	65.72M	75.1M	61.62M	n/a	n/a	20.09M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.63M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	10K	396K	472K	377K	413K	385K	1K	27K	n/a	n/a	n/a	29K	29K	29K	136K	29K	608K	1.49M	2.96M	2.41M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	39K	n/a	n/a	n/a	21K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-39K	n/a	n/a	n/a	-21K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	248K	1.08M	1.3M	894K	367K	682K	961K	336K	n/a	350K	n/a	n/a	1.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	19.66M	15.69M	20.44M	26.6M	11.61M	15.27M	20.05M	34.5M	39.67M	45.07M	51.73M	58.22M	67.08M	74.5M	76.05M	88.82M	99.24M	95.11M	17.66M	36.27M
Property-Plant & Equipment	119K	130K	138K	153K	167K	187K	199K	144K	n/a	290K	2.29M	2.33M	1.98M	2.11M	2.01M	2M	1.95M	1.79M	1.78M	1.98M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	129K	526K	610K	530K	580K	572K	200K	171K	n/a	290K	2.29M	2.36M	2.01M	2.14M	6.77M	2.03M	2.55M	3.28M	4.74M	4.39M
Total Assets	19.79M	16.21M	21.05M	27.13M	12.19M	15.85M	20.25M	34.67M	39.67M	45.36M	54.02M	60.59M	69.09M	76.64M	82.82M	90.85M	101.79M	98.39M	22.4M	40.66M
Account Payables	2M	1.54M	2.14M	1.53M	1.42M	1.42M	1.74M	2.06M	1.71M	498K	1.01M	541K	527K	2.07M	2.1M	1.96M	2.51M	4.56M	2.21M	4.64M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.02M	1.23M	463K	1.83M	8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	30K	1.27M	1.63M	89K	n/a	n/a	9.84M	1.08M	1.73M	1.3M	1.47M	1.24M	959K	893K	3.04M	2.15M	1.62M	2.68M	3.24M
Total Current Liabilities	3.68M	3.78M	3.91M	4.29M	4.03M	3.69M	4.02M	12.65M	3.7M	3.76M	4.33M	4.23M	4.06M	4.49M	4.14M	6.28M	7M	7.74M	7.2M	12.25M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.7M	3.4M	3.3M	5.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	12K	13K	12K	n/a	10K	n/a	n/a
Total Long-Term Liabilities	1.7M	3.4M	3.3M	5.6M	n/a	n/a	n/a	n/a	5.16M	n/a	n/a	102K	8K	12K	13K	12K	11K	10K	n/a	n/a
Total Liabilities	5.38M	7.18M	7.21M	9.89M	4.03M	3.69M	4.02M	12.65M	3.7M	3.76M	4.33M	4.33M	4.07M	4.5M	4.15M	6.29M	7.01M	7.75M	7.2M	12.25M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	203K	302K	398K	491K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	3K	3K	3K	1K	1K	1K	1K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	1K	n/a
Retained Earnings	-159.76M	-155.51M	-149.89M	-145.93M	-146.06M	-141.92M	-137.3M	-131M	-204.79M	-197.39M	-187.58M	-179.34M	-169.19M	-160.51M	-152.52M	-144.82M	-133.37M	-124.22M	-119.5M	-105.84M
Comprehensive Income	4K	4K	-9K	-17K	2K	n/a	n/a	n/a	-37K	-123K	-179K	-176K	-16K	6K	6K	n/a	-4K	n/a	n/a	3K
Shareholders Equity	14.41M	9.03M	13.84M	17.25M	8.16M	12.16M	16.22M	22.02M	35.97M	41.6M	49.69M	56.26M	65.02M	72.14M	78.67M	84.56M	94.79M	90.63M	15.21M	28.41M
Total Investments	10.73M	5.45M	14.08M	18.95M	5.71M	2.95M	n/a	9.78M	21.82M	33.46M	36.82M	46.92M	50.31M	61.1M	70.35M	75.1M	61.62M	n/a	n/a	20.09M